Prokarum Raises $21M to Develop Microbial Cancer Immunotherapies and Vaccines
Prokarium is developing Vesibax, an innovative, safe, and effective microbial immunotherapy (MI) for early-stage bladder cancer, a disease with afflicts ...
Tag: Riyadh Valley Company (RVC)